SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function
- 2 March 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 14 (672)
- https://doi.org/10.1126/scisignal.abb4282
Abstract
Loss of the transcription factor SOX9 reduces experimentally induced kidney fibrosis in mice.Keywords
Funding Information
- Wellcome (105610)
- Medical Research Council (MR/J003352/1 & MR/P023541/1)
- Medical Research Council (MR/000638/1 & MR/S036121/1)
- National Institute for Health Research
- National Institute for Health Research
- Kidney Research UK
- Kidneys for Life
This publication has 55 references indexed in Scilit:
- Mechanosensing and fibrosisJCI Insight, 2018
- SOX 9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosisEMBO Molecular Medicine, 2017
- PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosisNature Communications, 2016
- YAP/TAZ Are Mechanoregulators of TGF-β-Smad Signaling and Renal FibrogenesisJournal of the American Society of Nephrology, 2016
- Cellular and molecular mechanisms in kidney fibrosisJCI Insight, 2014
- Matrix-Producing Cells in Chronic Kidney Disease: Origin, Regulation, and ActivationCurrent Pathobiology Reports, 2013
- Tissue mechanics and fibrosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- TGFβ receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cellsJournal of Cell Science, 2013
- Cellular and molecular mechanisms of renal fibrosisNature Reviews Nephrology, 2011
- Hepatic stellate cells require a stiff environment for myofibroblastic differentiationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011